Dr Shi Yin Foo joins the Board as a Non-Executive Director (NED), while Dr Gary Burgess is confirmed as Chief Medical Officer (CMO). Both bring extensive experience in the cardiovascular drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback